Last reviewed · How we verify
68Ga-NODAGA-SNA006 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
68Ga-NODAGA-SNA006 (68Ga-NODAGA-SNA006) — SmartNuclide Biopharma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 68Ga-NODAGA-SNA006 TARGET | 68Ga-NODAGA-SNA006 | SmartNuclide Biopharma | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 68Ga-NODAGA-SNA006 CI watch — RSS
- 68Ga-NODAGA-SNA006 CI watch — Atom
- 68Ga-NODAGA-SNA006 CI watch — JSON
- 68Ga-NODAGA-SNA006 alone — RSS
Cite this brief
Drug Landscape (2026). 68Ga-NODAGA-SNA006 — Competitive Intelligence Brief. https://druglandscape.com/ci/68ga-nodaga-sna006. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab